SCHEMBL7943370

SCHEMBL7943370

O=C1NC(=O)[C@H](c2cc3ncccc3o2)N1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.56
▸ CHRNA4 P43681 2/20 0.56
▸ CHRM2 P08172 1/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ CHRM5 P08912 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ ADAM17 P78536 1/20 0.33
▸ GABRP O00591 3/20 0.33
▸ GABRD O14764 3/20 0.33
▸ GABRA1 P14867 3/20 0.33
▸ GABRB1 P18505 3/20 0.33
▸ GABRG2 P18507 3/20 0.33
▸ GABRB3 P28472 3/20 0.33
▸ GABRA5 P31644 3/20 0.33
▸ GABRA3 P34903 3/20 0.33
▸ GABRA2 P47869 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17570766 0.78 TDP1 (0.36) CHRNB2CHRNA4TDP1ALDH1A1MAPT
SCHEMBL13948553 0.78 TDP1 (0.36) CHRNB2CHRNA4TDP1ALDH1A1MAPT
SCHEMBL22023442 0.76 CHRNB2 (0.50) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL7942847 0.75 FAAH (0.37) TDP1ALDH1A1MAPTDDB1CRBN
SCHEMBL8232751 0.74 TDP1 (0.33) TDP1ALDH1A1MAPTGABRPGABRD
SCHEMBL7946203 0.74 PARP1 (0.37) GAAMMP12
SCHEMBL7947024 0.73 POLB (0.40) TDP1ALDH1A1MAPTGAAADORA2B
SCHEMBL7945506 0.72 TDP1 (0.36) TDP1ALDH1A1MAPTADAM17GAA
SCHEMBL7842456 0.71 CHRNB2 (1.00) CHRNB2CHRNA4CHRM2CHRM4CHRM5
SCHEMBL14467196 0.71 DAO (0.48) TDP1ALDH1A1MAPTADAM17DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010054278-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2010-05-14 — — WO disclosed
Send feedback